Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1973-10-30
1976-05-11
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
2602564Q, 2602475DP, A61K 31505
Patent
active
039564959
ABSTRACT:
2,4-diaminoquinazolines are employed as antithrombotic agents and have the following general formula: ##SPC1##
Wherein R.sub.1 and R.sub.2 are monovalent groups independently selected from the group consisting of ##EQU1## wherein R.sub.4 and R.sub.5 independently are selected from the group consisting of hydrogen, alkyl, and cycloalkyl, with the proviso that both R.sub.4 and R.sub.5 cannot be cycloalkyl, ##EQU2## wherein R.sub.6, R.sub.7, and R.sub.8 independently are selected from the group consisting of hydrogen and alkyl, and A is a divalent organic group having from two to about six carbon atoms such that the two nitrogen atoms are separated by at least two carbon atoms, and
REFERENCES:
patent: 2794018 (1957-05-01), Spinks et al.
patent: 2945859 (1960-07-01), Hitchings et al.
patent: 3511836 (1970-05-01), Hess
Drezin Norman A.
Eli Lilly and Company
Maycock William E.
Smith Everet F.
LandOfFree
2,4-Diaminoquinazolines as antithrombotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,4-Diaminoquinazolines as antithrombotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4-Diaminoquinazolines as antithrombotic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1304385